Does gender influence the impact of impaired renal function on prognosis after ST-segment elevated myocardial infarction? by Choi, Joon Seok et al.
Address for correspondence: Soo Wan Kim, MD, PhD, Department of Internal Medicine, Chonnam National University  
Medical School, 42 Jebongro, Gwangju 501-757, Korea, tel: +82-62-220-6271, fax: +82-62-225-8578,  
e-mail: skimw@chonnam.ac.kr
*Korea Acute Myocardial Infarction Registry Investigators are listed in Appendix 1.
Received: 07.11.2012 Accepted: 15.02.2013
original article
Cardiology Journal 
2013, Vol. 20, No. 5, pp. 526–532
DOI: 10.5603/CJ.2013.0138
Copyright © 2013 Via Medica
ISSN 1897–5593
526 www.cardiologyjournal.org
Does gender influence the impact of  
impaired renal function on prognosis after  
ST-segment elevated myocardial infarction?
Joon Seok Choi1, Min Jee Kim1, Yong Un Kang1, Chang Seong Kim1, Eun Hui Bae1,  
Seong Kwon Ma1, Young-Keun Ahn1, 2, Myung Ho Jeong1, 2, Young Jo Kim3,  
Myeong Chan Cho4, Chong Jin Kim5, Soo Wan Kim1;  
other Korea Acute Myocardial Infarction Registry Investigators*
1Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea 
2Cardiovascular Research Institute of Chonnam National University, Gwangju, Korea 
3Department of Internal Medicine, Yeungnam University, Daegu, Korea 
4Department of Internal Medicine, Chungbuk National University, Cheongju, Korea 
5Department of Internal Medicine, Kyunghee University, Seoul, Korea
Abstract
Background: A limited number of studies have investigated the impact of gender on renal 
function and clinical outcomes after ST-segment elevated myocardial infarction (STEMI), and 
these studies have provided discrepant results.
Methods and Results: This study was based on a retrospective cohort, the Korean Acute 
Myocardial Infarction Registry (KAMIR). Patients (n = 7,679) with a discharge diagnosis 
of STEMI were analyzed to investigate association of gender with renal function and clinical 
outcomes. Compared to men, women were older and exhibited more comorbidity, including 
impaired renal function. Women showed higher mortality compared to men (1-month morta-
lity, 5.6% in men vs. 12.6% in women, p < 0.001; 1-year mortality, 6.8% in men vs. 14.4% 
in women, p < 0.001). The risk of death proportionally increased as estimated glomerular 
filtration rate (eGFR) decreased in both genders. After adjusting for potential confounders, 
hazard ratios for women did not significantly differ from those for men at each eGFR level. 
The interaction test showed no significant interaction between gender and eGFR in 1-month 
mortality and 1-year mortality.
Conclusions: Impaired renal function was an independent prognostic factor after STEMI 
in both genders, and the impact of impaired renal function on prognosis after STEMI did not 
significantly differ between genders. (Cardiol J 2013; 20, 5: 526–532)
Key words: gender, impaired renal function, ST-segment elevated myocardial 
infarction
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Introduction
Impaired renal function is a well-known in-
dependent risk factor for mortality and morbidity 
in patients with myocardial infarction (MI) [1, 2]. 
Several studies reported that impaired renal fun-
ction is more prevalent in women, while female 
MI patients are generally older and have more 
comorbidity than male patients [2, 3]. The impact 
of gender difference on prognosis after ST-segment 
elevated MI (STEMI) has been a popular and de-
bated topic in clinical practice [4–10]. Although 
many studies on the issue have consistently sho-
wed higher mortality in women compared with 
men after STEMI [4–10], a limited number of 
studies have investigated gender influence on the 
prognostic impact of impaired renal function in 
patients with STEMI. Moreover, published studies 
yielded discrepant results regarding the impact of 
gender on the relationship between renal function 
and clinical outcomes in STEMI patients [11, 12]. 
Therefore, we undertook the present study to 
investigate how gender influences the prognostic 
impact of impaired renal function in patients with 
STEMI, in a cohort registered in the Korea Acute 
Myocardial Infarction Registry (KAMIR).
Methods
Korea Acute Myocardial Infarction Registry
The study population was derived from the 
KAMIR. The KAMIR is a Korean prospective, 
open, observational, multi-center online registry 
investigating the risk factors of mortality in MI pa-
tients since November 2005. Details of the KAMIR 
have been published elsewhere [2, 13]. We asses-
sed a cohort of 8,063 consecutive patients who 
were admitted to the hospital between November 
1, 2005, and July 31, 2008, and had a discharge diag-
nosis of STEMI, confirmed by both cardiac enzyme 
and electrocardiographic analyses. The diagnosis 
of STEMI was based on a suggestive history, with 
ST elevation > 2 mm in ≥ 2 precordial leads, 
ST elevation > 1 mm in ≥ 2 limb leads, or new left 
branch bundle block on a 12-lead electrocardiogram 
with a concomitant increase of cardiac markers 
≥ twice the normal upper limit. We excluded 
patients who were not available for estimation of 
glomerular filtration rate (GFR) or who did not 
complete at least 1 year of follow-up. A final popu-
lation of 7,679 patients was analyzed in this study.
Assessment of renal function
Renal function was assessed based on esti-
mated GFR (eGFR). The Chronic Kidney Disease 
Epidemiology Collaboration (CKD-EPI) equation 
was used to calculate eGFR in mL/min/1.73 m2 [14]. 
The eGFR was categorized as ≥ 90, 60–89, 30–59, 
and < 30 mL/min/1.73 m2, based on National Kid-
ney Foundation (NKF) Kidney Disease Outcomes 
Quality Initiative (KDOQI) chronic kidney disease 
(CKD) stages, but patients with CKD stages 4 and 
5 were combined because of relatively small num-
bers in this category.
Statistical analysis
Continuous variables with normal distributions 
are presented as mean ± standard deviation and com-
pared using Student’s t-test. Continuous variables 
with skewed distributions are presented as median 
(with 25th and 75th percentiles) and compared using the 
Mann-Whitney U test. Pearson’s c2 test or Fisher’s 
exact test was used to evaluate differences among 
categorical variables. Survival analysis after STEMI 
was estimated using the Kaplan-Meier method to 
compare survival among groups. Association of renal 
function and clinical outcomes in men and women was 
assessed using a Cox proportional hazard model with 
adjustment for confounders. Analyzed confounders 
included age, body mass index (BMI), comorbidities 
(hypertension, diabetes mellitus [DM], ischemic 
heart disease, hyperlipidemia, smoking status), Killip 
class ≥ 2, initial treatment strategies, percutaneous 
coronary intervention (PCI), angiographic findings, 
and medical treatments during hospitalization. The 
interaction between gender and renal function was 
assessed by entering an interaction term in the Cox 
proportional hazards model. All statistical tests were 
2-tailed, and p < 0.05 was considered significant. Sta-
tistical analysis was performed using the Statistical 
Package for Social Sciences software, version 18.0 
(SPSS, IBM, Armonk, NY USA).
Results
Patients’ baseline characteristics are presented 
in Table 1. A total of 7,679 patients took part in the 
study, including 5,652 men (age, 59.8 ± 12.8) and 
2,027 women (age, 71.4 ± 10.0). Women were older 
and had a higher prevalence of impaired renal fun-
ction (20.2% vs. 38.9%, p < 0.001, defined as eGFR 
< 60 mL/min/1.73 m2), hypertension, and DM, but 
had a lower BMI, eGFR, and rate-of-smoking history 
than men. Serum glucose, total cholesterol, low 
density lipoprotein cholesterol, and high density 
lipoprotein cholesterol were higher, while cardiac 
biomarkers and triglycerides were lower in women. 
At the time of arrival, women had a lower blood 
pressure and higher Killip class. Left ventricular 
ejection fraction did not differ between genders.
With regard to initial treatment strategy, con-
servative treatment was more commonly performed 
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in women, while PCI was undertaken at similar 
rates in both genders. However, many patients who 
did not undergo primary PCI underwent PCI befo-
re discharge, and overall PCI was less frequently 
performed in women (Table 2). Women exhibited 
more multivessel involvement and less optimal 
post-procedure thrombosis in MI (TIMI) flow on an-
giographic findings (Table 3). During hospitalization, 
standard medications known to improve survival after 
MI, such as anti-platelet agents, beta-blockers, and 
angiotensin-converting-enzyme inhibitors or angio-
tensin-receptor-blockers were less frequently used 
in women, while the use of anti-coagulation drugs 
and statins did not differ between genders (Table 2).
Subsequently, we analyzed baseline charac-
teristics, hospital treatments and angiographic 
findings in patients with eGFR < 60 mL/min/1.73 m2. 
As showed in all patients, there were similar 
differences between both genders with regard to 
baseline characteristics (Table 1), and hospital 
treatments and angiographic findings did not differ 
between genders (Tables 2 and 3).
Clinical outcomes were assessed by analysis 
of 1-month and 1-year mortalities. Women showed 
significantly higher mortality than men after STEMI 
(1-month mortality, 5.6% in men vs. 12.6% in 
women, p < 0.001; 1-year mortality, 6.8% in men 
vs. 14.4% in women, p < 0.001). Kaplan-Meier 
survival curves with log-rank test showed pro-
portionally increased mortality according to the 
eGFR category in both genders (Fig. 1). To adjust 
for possible confounding factors, Cox proportional 
regression analysis was performed. Decreased renal 
function was proportionally associated with incre-
ased unadjusted 1-month and 1-year mortalities 
in both genders. After adjusting for potential con-
founders, eGFR level less than 60 mL/min/1.73 m2 
remained a strong independent predictor for 
1-month and 1-year mortalities in both genders 
(Table 4). At each eGFR level, hazard ratios for wo-
men did not differ significantly from those for men. 
We performed an interaction test to investigate 
whether gender influenced mortality at each eGFR 
level after STEMI. The interaction test showed no 
significant interaction between gender and eGFR in 
1-month mortality and 1-year mortality (p = 0.928, 
p = 0.903, respectively).
Discussion
In the present study, female STEMI patients 
were older and had more comorbidity, including 
impaired renal function, than males, which is con-
sistent with the results of previous studies [4–10]. 
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With regard to hospital management of STEMI, 
a higher proportion of patients received conser-
vative treatment as an initial treatment strategy, 
and PCI was less frequently performed during 
the in-hospital period in women. Indeed, standard 
medications known to improve survival after MI 
Figure 1. A. One-year mortality Kaplan-Meier curves according to estimated glomerular filtration rate (eGFR) category 
in men; B. One-year mortality Kaplan-Meier curves according to eGFR category in women.
Table 3. Angiographic findings in both genders.
Total Patients with eGFR 60 mL/min/1.73 m2
Men  
(n = 5,652)
Women  
(n = 2,027)
P* Men  
(n = 1,144)
Women  
(n = 789)
P**
Number of diseased vessels < 0.001 0.33
Single 2492 (47.6%) 732 (40.2%) 363 (35.2%) 223 (32.1%)
Double 1543 (29.5%) 581 (31.9%) 336 (32.6%) 229 (33.0%)
Triple 1075 (20.5%) 463 (25.4%) 288 (28.0%) 219 (31.6%)
Left main disease 125 (2.4%) 45 (2.5%) 43 (4.2%) 23 (3.3%)
Lesion type 0.36 0.18
A 214 (4.4%) 69 (4.0%) 41 (4.3%) 26 (4.0%)
B1 869 (17.8%) 297 (17.2%) 144 (15.2%) 125 (19.2%)
B2 1304 (26.8%) 436 (25.3%) 224 (23.6%) 155 (23.8%)
C 2486 (51.0%) 921 (53.5%) 539 (56.9%) 345 (53.0%)
Pre procedural TIMI flow grade 0.13 0.39
0 2633 (52.4%) 983 (55.6%) 540 (54.7%) 380 (56.7%)
I 545 (10.9%) 177 (10.0%) 110 (11.1%) 66 (9.9%)
II 744 (14.8%) 252 (14.3%) 164 (16.6%) 95 (14.2%)
III 1100 (21.9%) 355 (20.1%) 174 (17.6%) 129 (19.3%)
Post procedural TIMI flow grade < 0.001 0.35
0 98 (2.0%) 48 (2.8%) 31 (3.3%) 28 (4.3%)
I 58 (1.2%) 24 (1.4%) 18 (1.9%) 12 (1.8%)
II 212 (4.3%) 134 (7.8%) 61 (6.4%) 54 (8.2%)
III 4523 (92.5%) 1514 (88.0%) 843 (88.5%) 562 (58.7%)
*compared between men and women; **compared between men with eGFR < 60 mL/min/1.73 m2 and women with eGFR < 60 mL/min/1.73 m2; 
eGFR — estimate glomerular filtration rate; TIMI — thrombosis in myocardial infarction
were less frequently used in women. Although wo-
men showed higher mortality in the present study, 
this might be attributed to differences in baseline 
characteristics and hospital management intens-
ity. Previous studies reported conflicting results 
about gender effects on mortality after adjusting 
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for multiple confounding factors. Some showed 
no gender effect on mortality after adjustment 
[4, 5, 7, 9], and others concluded that gender was an 
independent risk factor for mortality after STEMI 
[6, 8, 10]. Recently, Kang et al. [9] reported that 
the gender effect was accounted for mostly by older 
age in women, complex comorbidities, and severe 
hemodynamic conditions at presentation; their 
study analyzed merged data from the KAMIR and 
the Korean Myocardial Infarction (KorMI) registry.
Previous studies regarding gender effects on 
the impact of impaired renal function in prognosis 
after STEMI produced highly discrepant and incon-
clusive results [3, 11, 12]. In the present study we 
investigated whether gender influences the impact 
of impaired renal function in STEMI patients, and 
we found that the impact of impaired renal function 
on prognosis after STEMI did not significantly differ 
between genders. Sederholm Lawesson et al. [12] 
reported that the association between impaired re-
nal function and outcome after STEMI is stronger 
in women than in men. In that study no progno-
stic impact of renal function on clinical outcomes 
was observed in men; in contrast, in women each 
10 mL/min/1.73 m2 increment of eGFR was associated 
with 63% lower risk of death. The interaction test 
between gender and impaired renal function showed 
significant differences with respect to mortality. 
However, we found the opposite in our analysis. 
The 1-year mortality after STEMI proportionally 
increased as eGFR decreased, and this impact 
persisted even after adjusting for potential confo-
unders in both genders. The hazard ratios in each 
eGFR category were similar in both genders, and 
the interaction test showed insignificant results. 
Sederholm Lawesson et al. [12] included an insuffi-
cient number of patients (total, 247) to demonstrate 
a gender effect between impaired renal function and 
mortality. Chen et al. [3] also reported that gender 
might influence the prognostic effect of impaired 
renal function in coronary artery disease patients. 
In that study they analyzed 1,609 patients enrolled 
from 1996 to 1997. However, given the recent re-
markable advances in treatment of STEMI patients 
and in quality control, the significance of that study 
is limited. Recently, Damman et al. [11] have raised 
questions about previous studies that investigated 
gender effects on impaired renal function and clini-
cal outcomes. They showed a stronger association 
between impaired renal function and outcomes in 
both genders. In contrast to previous studies, they 
found that hazard ratios at each eGFR category were 
higher in men than in women, and an interaction 
test between gender and impaired renal function Ta
b
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showed significance in overall mortality. Although, 
Damman et al. [11] analyzed a relatively large 
number of patients compared to previous studies, 
the data were based on a single-center-registry, 
and a significantly higher hazard ratio in men was 
needed for verification.
Our study has several distinctive advantages 
compared to previous studies. Firstly, the study 
population was derived from a multi-center online 
registry and large-scale cohort populations were 
analyzed. This is likely to improve statistical relia-
bility. Secondly, the CKD-EPI equation was used to 
estimate eGFR. This equation was recently descri-
bed as an improved method of GFR estimation that 
is more accurate and provides stronger prognostic 
value than older methods [14, 15].
The present study has several limitations. 
Although we adjusted for multiple confounding fac-
tors, it is possible that some unmeasured confoun-
ders remain. Moreover, the assessment of kidney 
function was based on a single serum creatinine 
value obtained at the time of presentation to the 
hospital. This value could have been affected by 
hemodynamic or metabolic status.
Conclusions
In conclusion, we demonstrated that impaired 
renal function was an independent prognostic factor 
after STEMI in both genders, and confirmed that 
the impact of impaired renal function on prognosis 
after STEMI did not significantly differ between 
genders. Our study does not support the notion 
that gender influences the association between 
impaired renal function and clinical outcome after 
STEMI. Our findings broaden current understan-
ding of the role of gender in patients with STEMI.
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